Related Experiment Video

Updated: Jul 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

[Intracerebral calcinosis as intra-axial manifestation of scleroderma en coup de sabre]

M Wagner, B Wiese, F Heidenreich

    Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
    |May 28, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

    Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

    Published on: May 31, 2016

    Calcium Imaging in Mouse Superior Colliculus10:43

    Calcium Imaging in Mouse Superior Colliculus

    Published on: April 21, 2023

    Related Concept Videos

    Cerebral Edema ll: Pathophysiology01:22

    Cerebral Edema ll: Pathophysiology

    Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

    Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

    Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...